Bruker ICON™ by Bruker BioSpin

Manufacturer Bruker BioSpin  |  Available Worldwide
Easy-to-use and cryogen-free high-performance compact MRI desktop system

Bruker ICON™ by Bruker BioSpin product image
Bruker ICON™
Request Pricing

Receive your quote directly from the manufacturer.

0 Scientists have reviewed this product

Write the First Review

No Reviews

Our most advanced preclinical Optical/X-ray imaging system.

Bringing a new level of sensitivity, speed and versatility to preclinical imaging, the In-Vivo Xtreme II offers researchers greater scope to discover important biological mechanisms in disease, treatments and monitoring.

Five imaging modalities are provided as standard, allowing co-registration of molecular events with access to Bioluminescence, Multispectral VIS- NIR Fluorescence, unique Direct Radioisotopic Imaging, and Cherenkov radiation. A high speed digital X-ray with industry leading resolution and reflectance modes enhances data acquisition with anatomical features.

Watch the webinar to discover how the In-Vivo Xtreme II is enabling in vivo tumor progression studies.


  • New camera for higher sensitivity.
  • Exceptionally low read noise electronics enables previously unattainable levels of detection during low-light applications.
  • Novel dual heating and isoflurane anaesthesia system provides optimal environment for animal imaging and welfare.
  • Innovative animal tray design and active evacuation system isolates users from 99.9% of harmful gas exposure.
  • SPF suitable animal imaging chambers.
  • Fully compatible with multimodal product family.


  • Tumor and stem cell tracking.
  • Luminescence imaging of inflammation.
  • Optical imaging of PET probes with either Direct Radioisotopic Imaging (DRI) or Cherenkov radiation.
  • Tracking and validating single or multimodal nanoparticles.
  • Imaging and validating new probes and biomarker.
  • Non-invasively image changes in signaling cascades.
  • Discover how genetics, small molecules and therapeutics affect biochemical pathways.
  • Quantify changes in bone and soft tissue phenotype.
  • High throughput pharmacodynamic studies.